ଓଡ଼ିଆ | ENGLISH
ଓଡ଼ିଆ | ENGLISH

AIIMS Bhubaneswar inaugurates three upgraded laboratory services to strengthen diagnostic facilities

Published By : Chinmaya Dehury | November 16, 2026 5:17 PM
AIIMS Bhubaneswar inaugurates three upgraded laboratory services to strengthen diagnostic facilities

Bhubaneswar, Nov 16: In a significant step towards strengthening diagnostic healthcare, AIIMS Bhubaneswar has inaugurated three upgraded laboratory facilities under its Department of Biochemistry.

These are Antenatal & New-born Screening Laboratory, Immunology Laboratory and HPLC Laboratory. The initiative aims to enhance the quality, accuracy and accessibility of specialised diagnostic services.

The facilities were inaugurated by Prof. (Dr.) Ashutosh Biswas, Executive Director & CEO, AIIMS Bhubaneswar, in the presence of Dr. Dillip Kumar Parida, Dean (Academic), Dr. Prabhas Ranjan Tripathy, Medical Superintendent, and Dr. Manaswini Mangaraj, Dean (Examination) and Head, Department of Biochemistry.

Highlighting the significance of the initiative, Dr. Biswas stated that the advanced platform can detect very low concentrations of substances in samples such as urine and cerebrospinal fluid (CSF), opening up new diagnostic possibilities. This facility is not currently available at any other government healthcare institution in Odisha.

The Antenatal & New-born Screening Laboratory has been equipped with a new Revvity Victor 2D Fluorometer for more sensitive and accurate screening. Seven new-born screening parameters have been standardised and integrated with the Hospital Management Information System (HMIS) for online reporting. Screening for Phenylketonuria (PKU) and Cystic Fibrosis (CF), through Immunoreactive Trypsinogen (IRT), will also be introduced.

The laboratory will additionally offer specialised antenatal screening, including dual-marker (free β-hCG and PAPP-A), triple-marker (with unconjugated estriol) and penta-marker (with AFP and PlGF) tests, supported by built-in software for risk prediction. This comprehensive antenatal screening facility is also not currently available at any other government healthcare institution in Odisha.

The Immunology Laboratory has been strengthened with a Siemens Atellica NEPH 630 Nephelometer, currently offering six important tests: IgG, IgA, IgM, IgE, C3 and C4. The system has been calibrated and integrated with HMIS for online reporting.

The laboratory plans to expand its test menu to include IgG subclasses (IgG1–IgG4), free light chains (kappa and lambda), ASO, RF, Cystatin C, Homocysteine, Lp(a), Transferrin, soluble transferrin receptor (sTfR), Haptoglobin, Hemopexin, C1 Esterase Inhibitor, α1-Antitrypsin, Ceruloplasmin and β2-Microglobulin. Lymphocyte cross-matching services will also be introduced to support patients undergoing solid organ transplantation.

Also Read: NIT Rourkela secures patent for smart power management system for EV charging stations

High-Performance Liquid Chromatography (HPLC) is considered the gold standard for HbA1c testing, an important investigation for diabetes diagnosis and monitoring. AIIMS Bhubaneswar is the first AIIMS institution to procure this high-throughput analyser, further strengthening its diagnostic infrastructure.

Through these initiatives, AIIMS Bhubaneswar aims to provide advanced, high-quality and affordable diagnostic services to patients from Odisha and neighbouring states. The upgraded facilities are expected to improve access to specialised investigations, enhance diagnostic capabilities and reduce the need for patients to travel outside the state for advanced testing.